Brief: Alpine Immune Sciences Shares Updated Clinical Data From Povetacicept in IgA Nephropathy
10/04/2024 22:14
April 10 (Reuters) - Alpine Immune Sciences Inc
ALPN.O :
* ALPINE IMMUNE SCIENCES SHARES UPDATED CLINICAL DATA FROM
POVETACICEPT IN IGA NEPHROPATHY
* ALPINE IMMUNE SCIENCES INC - POVETACICEPT ADMINISTERED
SUBCUTANEOUSLY ONCE EVERY FOUR WEEKS CONTINUES TO BE WELL
TOLERATED IN IGA NEPHROPATHY
Source text for Eikon: ID:nBw1w2NJra
Further company coverage: ALPN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpine Immune Sciences
See all newsAlpine Immune Sciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Alpine Immune Sciences Q1 EPS USD -0.28 Vs. IBES Estimate USD -0.41
Moves: Lazard hires veteran healthcare dealmaker Colocci as vice chairman
U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse
US STOCKS-S&P 500, Nasdaq end sharply higher on soft inflation data, eyes on earnings